Please provide your email address to receive an email when new articles are posted on . Patients with atopic dermatitis that were resistant to systemic therapies, including dupilumab, were treated ...

Minimal disease activity in atopic dermatitis is sustainable at one year in early responders. Discover predictors and ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. The current treatment options for atopic ...

Lawrence F. Eichenfield, MD, FAAD, from Rady Children's Hospital and UC San Diego School of Medicine, highlighted the effectiveness of ruxolitinib cream as a nonsteroidal topical treatment for atopic ...

Experts discuss the importance of balancing effective symptom control with quality of life in managing chronic pediatric atopic dermatitis, emphasizing personalized treatment plans that address both ...

High-dose upadacitinib was found to be most effective in improving AD and itch severity, quality of life and AD flares, but was determined to be among the most harmful with regard to adverse events.

Managing atopic dermatitis (AD, also known as eczema) can be fraught with uncertainty about when the next flare-up will happen. You may go weeks or even months without any symptoms, only to have acute ...

Patients with atopic dermatitis (AD) are at increased risk of skin infections due to impaired skin barrier function and a dysregulated immune system; extracutaneous and systemic infections may also ...

Young children with moderate-to-severe atopic dermatitis (AD) are shorter on average than their peers. Researchers hypothesized that sleep deprivation or long-term exposure to topical or systemic ...

Many eczema patients skip the mental health talk. Learn how to discuss anxiety and depression with your dermatologist to unlock better treatment options and systemic therapies.

Although previous research has demonstrated the superiority of various herbal medicines over comparator therapies for atopic dermatitis, there are insufficient data to warrant any specific ...